Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85,874 | 123,456 | 106,336 | 46,928 | 68,809 |
| Marketable Securities | 278,521 | 128,942 | 97,870 | 186,452 | 189,936 |
| TOTAL | $378,413 | $264,493 | $213,055 | $241,627 | $268,340 |
| Non-Current Assets | |||||
| PPE Net | 4,573 | 5,210 | 5,804 | 6,398 | 6,409 |
| Other Non-Current Assets | 1,427 | 1,738 | 7,249 | 6,509 | 7,056 |
| TOTAL | $6,000 | $6,948 | $13,053 | $12,907 | $13,465 |
| Total Assets | $384,413 | $271,441 | $226,108 | $254,534 | $281,805 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,925 | 2,373 | 4,274 | 5,693 | 6,440 |
| Accrued Expenses | 19,475 | 16,499 | 13,379 | 20,415 | 19,510 |
| Other current liabilities | N/A | N/A | N/A | 25 | N/A |
| TOTAL | $24,892 | $20,552 | $19,342 | $27,830 | $27,560 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,012 | 473 | 932 | 1,281 | 2,334 |
| TOTAL | $1,012 | $473 | $932 | $1,281 | $2,334 |
| Total Liabilities | $25,904 | $21,025 | $20,274 | $29,111 | $29,894 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,075 | 67,874 | 55,802 | 55,547 | 54,881 |
| Common Shares | 18 | 16 | 15 | 15 | 15 |
| Retained earnings | -463,816 | -419,980 | -382,511 | -356,092 | -324,295 |
| Other shareholders' equity | 6 | 9 | 240 | 33 | 62 |
| TOTAL | $358,509 | $250,416 | $205,834 | $225,423 | $251,911 |
| Total Liabilities And Equity | $384,413 | $271,441 | $226,108 | $254,534 | $281,805 |